Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0NM7 stock hub

LON/0NM7 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0NM7is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.6B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0NM7

In the news

Latest news · LON/0NM7

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.3

P25 n/aP50 n/aP75 n/a

Trailing P/E20

P25 n/aP50 n/aP75 n/a

ROE13.9

P25 n/aP50 n/aP75 n/a

ROIC12.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0NM7 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

EUR

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	6,442
Employees Change	77%
Employees Change Percent	1.21
Enterprise value	EUR 2.8B
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Isin	FR0000031577
Last refreshed	2026-05-10
Market cap	EUR 2.6B
Price	EUR 373
Price currency	EUR
Rev Per Employee	198,345.94x
Sic	2836
Symbol	lon/0NM7
Website	https://corporate.virbac.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.99%
EV Earnings	21.11x
EV/EBIT	13.97x
EV/EBITDA	11.03x
EV/FCF	29.84x
EV/Sales	2.2x
FCF yield	3.53%
Forward P/E	17.28x
P/B ratio	2.69x
P/E ratio	20.04x
P/S ratio	2.06x
PE Ratio10 Y	20.54x
PE Ratio3 Y	19.48x
PE Ratio5 Y	20.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.71%
EBITDA Margin	19%
FCF margin	7.29%
Gross margin	66.68%
Gross Profit	EUR 852.1M
Gross Profit Growth	2.18%
Gross Profit Growth Q	4.55%
Gross Profit Growth3 Y	3.04%
Gross Profit Growth5 Y	4.13%
Net Income	EUR 131.6M
Net Income Growth	3.85%
Net Income Growth Q	35.27%
Net Income Growth3 Y	2.24%
Net Income Growth5 Y	4.83%
Pretax Margin	14.86%
Profit Margin	10.3%
Profit Per Employee	EUR 20,433
ROA	7.65
Roa5y	8.57
ROCE	16.46
ROE	13.88
Roe5y	14.98
ROIC	12.35
Roic5y	16.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.9%
Cagr15y	8.91%
Cagr1y	22.04%
Cagr3y	8.59%
Cagr5y	7.3%
Div CAGR10	6.79%
Div CAGR3	3%
Div CAGR5	14.04%
EPS Growth	3.81
EPS Growth Q	35.17
EPS Growth3 Y	2.31
EPS Growth5 Y	5.02
FCF Growth	-20.91%
FCF Growth Q	6.71%
FCF Growth3 Y	5.37%
FCF Growth5 Y	3.13%
OCF Growth	-2.56%
OCF Growth Q	2.22%
OCF Growth10 Y	5.28%
OCF Growth3 Y	12.78%
OCF Growth5 Y	9.08%
Revenue Growth	4.82x
Revenue Growth Q	4.6x
Revenue Growth3 Y	3.03x
Revenue Growth5 Y	3.89x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.78
Assets	EUR 1.7B
Cash	EUR 110.1M
Current Assets	EUR 685M
Current Liabilities	EUR 446.6M
Debt	EUR 252.7M
Debt EBITDA	EUR 0.99
Debt Equity	EUR 0.26
Debt FCF	EUR 2.71
Equity	EUR 981.4M
Interest Coverage	26.05
Liabilities	EUR 688.5M
Long Term Assets	EUR 984.9M
Long Term Liabilities	EUR 241.8M
Net Cash	EUR -142.6M
Net Cash By Market Cap	EUR -5.41
Net Debt EBITDA	EUR 0.59
Net Debt Equity	EUR 0.15
Net Debt FCF	EUR 1.53
Tangible Book Value	EUR 469.4M
Tangible Book Value Per Share	EUR 56.03
WACC	8.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.53
Inventory Turnover	1.25
Net Working Capital	EUR 231.1M
Quick ratio	0.77
Working Capital	EUR 240.4M
Working Capital Turnover	EUR 3.9

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.06%
Dividend Growth	11%
Dividend Growth Years	1%
Dividend per share	EUR 1.24
Dividend Years	5
Dividend Yield	0.34%
Ex Div Date	2025-06-24
Last Dividend	EUR 1.24
Payout Frequency	Annual
Payout Ratio	8.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	156.96%
1Y total return	22.02%
200-day SMA	347.5
3Y total return	28.05%
50-day SMA	358
50-day SMA vs 200-day SMA	50over200
5Y total return	42.25%
All Time High	447
All Time High Change	-16.67%
All Time High Date	2021-11-01
All Time Low	49.71
All Time Low Change	649.35%
All Time Low Date	2008-11-26
ATR	8.36
Beta	0.81
Ch YTD	5.08
High	375.5
High52	385.5
High52 Date	2026-04-17
High52ch	-3.37%
Low	370.5
Low52	296
Low52 Date	2025-09-15
Low52ch	25.85%
Ma50ch	4.06%
Price vs 200-day SMA	7.18%
RSI	50.13
RSI Monthly	56.01
RSI Weekly	53.97
Sharpe ratio	0.65x
Sortino ratio	1.34
Total Return	0.28%
Tr YTD	5.08
Tr15y	259.61%
Tr1m	6.28%
Tr1w	1.36%
Tr3m	5.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 200.8M
Operating Income Growth	8.42
Operating Income Growth Q	22.36
Operating Income Growth3 Y	0.42
Operating Income Growth5 Y	5.49
Operating margin	15.71

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,125,190%
Net Borrowing	5,723,914.7
Shares Insiders	50.18%
Shares Institutions	21.03%
Shares Qo Q	0.12%
Shares Yo Y	0.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 93.1M
Average Volume	509.75x
Bv Per Share	117.2
CAPEX	EUR -80.5M
Ch10y	152
Ch15y	232.6
Ch1m	6.28
Ch1w	1.36
Ch1y	21.47
Ch3m	5.82
Ch3y	26.38
Ch5y	39.51
Ch6m	7.97
Change	1.5%
Change From Open	0.2
Close	367
Days Gap	1.29
Depreciation Amortization	41,627,054.9
Dollar Volume	8,940
Earnings Date	2026-09-17
EBIT	EUR 200.8M
EBITDA	EUR 242.8M
EPS	EUR 15.7
F Score	5
FCF	EUR 93.1M
FCF EV Yield	3.35x
Financing CF	-8,551,872
Fiscal Year End	December
Founded	1,968
Goodwill	307,998,857.6
Graham Number	240.75709
Graham Upside	-35.37
Income Tax	EUR 58.7M
Investing CF	-173,278,557
Is Primary Listing	0
Last Earnings Date	2025-09-12
Last Report Date	2025-12-31
Lynch Fair Value	EUR 92.94
Lynch Upside	-75.05
Ma150	353.5
Ma150ch	5.38%
Ma20	370
Ma20ch	0.66%
Net CF	-21,581,633
Next Earnings Date	2026-09-17
Open	371.8
P FCF Ratio	28.32
P OCF Ratio	15.2
Payment Date	2025-06-26
Position In Range	40
Ppne	399,430,111.9
Price Date	2026-05-07
Price EBITDA	EUR 10.87
Ptbv Ratio	5.62
Relative Volume	0.05x
Revenue	1,277,744,524x
Tax By Revenue	4.59x
Tax Rate	30.89%
Tr6m	7.97%
Volume	24
Z Score	3.52

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0NM7 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.3%

$1.24 annual per share

Payout ratio

+8.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+14.0%

1 consecutive years of growth

Total shareholder yield

+0.3%

Next ex-dividend date: 2025-06-24

Performance

LON/0NM7 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0NM7?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.0%

Share of float held by funds and institutions

Insider ownership

+50.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

LON/0NM7 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.1

Neutral momentum band

Price vs 200-day MA

+7.2%

50/200-day relationship not available

Beta (5Y)

0.81

Moves roughly with the market

Sharpe ratio

0.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0NM7

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0NM7 stock rating?

lon/0NM7 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0NM7 analysis?

The full report lives at /stocks/lon/0NM7/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0NM7?

The latest report frames lon/0NM7 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0NM7 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.